June 3, 2014 – The House Energy and Commerce Committee is seeking public comments from patients, providers and other stakeholders about how they learn about new treatments for their diseases or conditions, a discussion that is likely to fuel the debate over whether and how companies can disclose information about off-label uses for their products. […]
Read more